Home › Funds › Casdin Capital › PRME
Casdin Capital position in PRME
PRIME MEDICINE INC · Health Care
Latest position (Q2 2026)3.17M sh
Reported value held$11.69M
Portfolio Weight0.59%
First reportedQ4 2022
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2022 | 734.35K | $13.64M | New |
| Q1 2023 | 734.35K | $9.03M | Hold |
| Q2 2023 | 367.18K | $5.38M | Reduce |
| Q3 2023 | 367.18K | $3.50M | Hold |
| Q4 2023 | 367.18K | $3.25M | Hold |
| Q1 2024 | 367.18K | $2.57M | Hold |
| Q2 2024 | 367.18K | $1.89M | Hold |
| Q3 2024 | 367.18K | $1.42M | Hold |
| Q4 2024 | 367.18K | $1.07M | Hold |
| Q1 2025 | 367.18K | $730.68K | Hold |
| Q2 2025 | 1.57M | $3.87M | Add |
| Q3 2025 | 3.17M | $17.55M | Add |
| Q4 2025 | 3.17M | $10.99M | Hold |
| Q1 2026 | 3.17M | $11.02M | Hold |
| Q2 2026 | 3.17M | $11.69M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PRME
- BlackRock Inc 9.60M sh · $35.43M · Q2 2026
- ARK Invest 8.35M sh · $30.81M · Q2 2026
- Vanguard Group 6.47M sh · $22.44M · Q4 2025
- Balyasny Asset Management 3.97M sh · $14.65M · Q2 2026
- Goldman Sachs Group 3.43M sh · $12.66M · Q2 2026
- UBS Group AG 2.79M sh · $10.31M · Q2 2026
- Geode Capital Management 2.71M sh · $10.01M · Q2 2026
- Citadel Advisors 2.35M sh · $8.68M · Q2 2026
- Fidelity Management & Research (FMR) 1.76M sh · $6.50M · Q2 2026
- Two Sigma Investments 1.52M sh · $5.63M · Q2 2026
- Farallon Capital Management 1.24M sh · $4.58M · Q2 2026